Opinion|Videos|June 26, 2024
Payer Coverage Considerations for New Treatments for Alzheimer Disease
Experts discuss how payers can prepare for new treatments and plan adequate coverage for patients with Alzheimer disease.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- How can plan sponsors effectively prepare for these new treatments and plan coverage in a way that ensure adequate care for patients with Alzheimer disease and availability of coverage for all patients?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
CRC Becomes Leading Cause of Cancer-Related Death in Younger Adults, Highlighting Prevention Gaps
2
Novel CLL Therapies Prompt New Treatment Considerations
3
Teclistamab Transforms Early Myeloma Care: Roberto Mina, MD
4
Unexplained Pauses Hit Nearly Half of Monthly-Updated CDC Databases, Raising Transparency Concerns
5
